Litcius/Paper detail

Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection

Bette Liu, Heather F. Gidding, Sandrine Stepien, Michelle Cretikos, Kristine Macartney

2022Vaccine31 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVaccinationHazard ratioCohortPopulationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Cohort studyPediatricsImmunologyInternal medicineDiseaseConfidence intervalInfectious disease (medical specialty)Environmental healthSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyImmune responses and vaccinations
Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection | Litcius